EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.1.1.366 | Lung Neoplasms |
25477335 |
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
3
0 |
| 2.1.1.366 | Neoplasm Metastasis |
25477335 |
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
3
0 |
| 2.1.1.366 | Neoplasms |
25477335 |
H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
3
0 |
| 2.1.1.366 | [histone h3]-n6,n6-dimethyl-lysine9 n-methyltransferase deficiency |
20014010 |
KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation. |
unassigned |
0 |
